Go to page content

M.Sc. Student Presentation

Tuesday, Oct. 31, 1-2 p.m.

CSF-1302

Kaitlyn Mayne
M.Sc Student
Department of Biochemistry

Date: October 31, 2023
Time: 1:00-2:00 p.m.
Room: CSF-1302

 

CD24 is a cell surface protein known to be a rheostat in B lymphocyte (B cell) development in the bone marrow through the induction of apoptosis or inhibition of proliferation. However, CD24 lacks an intracellular signaling domain. Currently there are no known co-receptors of CD24 on B cells. Siglec-2 (CD22) and Siglec-G are both inhibitory sialic acid-binding immunoglobulin-like lectins (Siglecs), which are expressed on B cells and are known to interact with glycoproteins such as those on CD24. In other cells such as dendritic cells, Siglec G is a known ligand of CD24, but there is no data to suggest it has any effect on B cells of the bone marrow. CD22 has been found to have similar expression patterns to CD24 on certain developing B cells from the bone marrow, making it a good candidate to explore as a co-receptor. This study will contribute to understanding how CD24 regulates B cell development by aiming to identify its natural co-receptor in developing bone marrow B cells.

Presented by Department of Biochemistry

Event Listing 2023-10-31 13:00:00 2023-10-31 14:00:00 America/St_Johns M.Sc. Student Presentation Kaitlyn Mayne M.Sc Student Department of Biochemistry Date: October 31, 2023 Time: 1:00-2:00 p.m. Room: CSF-1302   CD24 is a cell surface protein known to be a rheostat in B lymphocyte (B cell) development in the bone marrow through the induction of apoptosis or inhibition of proliferation. However, CD24 lacks an intracellular signaling domain. Currently there are no known co-receptors of CD24 on B cells. Siglec-2 (CD22) and Siglec-G are both inhibitory sialic acid-binding immunoglobulin-like lectins (Siglecs), which are expressed on B cells and are known to interact with glycoproteins such as those on CD24. In other cells such as dendritic cells, Siglec G is a known ligand of CD24, but there is no data to suggest it has any effect on B cells of the bone marrow. CD22 has been found to have similar expression patterns to CD24 on certain developing B cells from the bone marrow, making it a good candidate to explore as a co-receptor. This study will contribute to understanding how CD24 regulates B cell development by aiming to identify its natural co-receptor in developing bone marrow B cells. CSF-1302 Department of Biochemistry